(Q46105785)

19 December 2017

title

Ischaemia versus bleeding: the art of clinical decision-making (English)

1 reference

19 December 2017

1 reference

1

Gregg W Stone

1 reference

19 December 2017

language of work or name

English

0 references

publication date

1 February 2009

1 reference

19 December 2017

published in

The Lancet

1 reference

19 December 2017

volume

373

1 reference

19 December 2017

issue

9665

1 reference

19 December 2017

page(s)

695-696

1 reference

19 December 2017

Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960413-X

7 January 2021

Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960413-X

7 January 2021

Angioplasty strategies in ST-segment-elevation myocardial infarction: part I: primary percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960413-X

7 January 2021

Decline in Rates of Death and Heart Failure in Acute Coronary Syndromes, 1999-2006

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960413-X

7 January 2021

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960413-X

7 January 2021

Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960413-X

7 January 2021

Time dependence of platelet inhibition after a 600-mg loading dose of clopidogrel in a large, unselected cohort of candidates for percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960413-X

7 January 2021

Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960413-X

7 January 2021

Prasugrel achieves greater and faster P2Y12receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960413-X

7 January 2021

Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myoc

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960413-X

7 January 2021

Adverse impact of bleeding on prognosis in patients with acute coronary syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960413-X

7 January 2021

Bivalirudin during primary PCI in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960413-X

7 January 2021

Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960413-X

7 January 2021

Prasugrel versus clopidogrel in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960413-X

7 January 2021

Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a r

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960413-X

7 January 2021

10.1016/S0140-6736(09)60413-X

Identifiers

DOI

1 reference

19 December 2017

1 reference

19 December 2017